Evidence map›Paper›PMID 40558050›Full record

ArticleMicrobiology spectrum2025

Gut health predictive indices linking gut microbiota dysbiosis with healthy state, mild gut discomfort, and inflammatory bowel disease phenotypes using gut microbiome profiling.

Joann Phan, Suneer Jain, Jurgen F Nijkamp, Rajkumar Sasidharan, Ashish Agarwal, Julia K Bird, Anneleen Spooren, Jonas Wittwer Schegg, Emiel Ver Loren van Themaat, Tim N Mak

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joann PhanSun Genomics, Inc., San Diego, California, USA.ORCID 0000-0001-5798-4416
Suneer JainSun Genomics, Inc., San Diego, California, USA.
Jurgen F Nijkampdsm-firmenich, Delft, The Netherlands.
Rajkumar SasidharanSolvuu, Inc., New York, New York, USA.
Ashish AgarwalSolvuu, Inc., New York, New York, USA.
Julia K BirdBird Scientific Writing, Wassenaar, The Netherlands.
Anneleen Spoorendsm-firmenich, Kaiseraugst, Switzerland.
Jonas Wittwer Scheggdsm-firmenich, Kaiseraugst, Switzerland.ORCID 0000-0002-8590-2657
Emiel Ver Loren van Themaatdsm-firmenich, Delft, The Netherlands.ORCID 0009-0005-1522-5856
Tim N Makdsm-firmenich, Kaiseraugst, Switzerland.ORCID 0009-0001-6161-2567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the complexity of the gut microbiome, several scores that use taxonomic characteristics exist that attempt to identify a healthy gut or gastrointestinal disease. Two systems in use are the metagenomic aerotolerant predominance index (MAPI) and keystone scores. The aim of this analysis was to compare different gut microbiome scores, specifically MAPI and a keystone species score, on two cross-sectional data sets and to investigate correlations of these scores with self-reported gut discomfort and gastrointestinal disease. The first data set is a commercial data set (Sun Genomics data set) with whole-genome shotgun sequencing samples from 5,372 customers. The second data set is curated from publicly available data (public data set) with 2,415 samples from participants in human studies with gut-related taxonomic profiles. MAPI scores and keystone species scores were calculated using standard methodology. The MAPI score was significantly lower in men for the public data set. There was a graded response for both the MAPI and keystone scores between healthy subjects, subjects with mild gastrointestinal discomfort, and patients with gastrointestinal disease: the MAPI score was higher, and the keystone score was lower in subjects with gastrointestinal discomfort or with inflammatory bowel disease patients. The keystone and MAPI scores have the potential to help identify factors associated with gut microbial dysbiosis and gastrointestinal discomfort or disease. Furthermore, given the functional link of the MAPI score to oxidative stress in the microbiome, the scores can help to identify conditions where oxidative stress is one of the hallmarks of dysbiosis.IMPORTANCEGut bacteria play a role in both mild gastrointestinal discomfort, which includes bloating and constipation, and inflammatory bowel disease. There are many different types of bacteria in the gut, and gut microbiome composition differs greatly between different people. Therefore, it is difficult to predict who has a gut microbiome associated with a healthy gut and who might develop disease or experience gut discomfort. Several scoring systems have been developed to categorize gut health states. This analysis compared two different scoring systems using data from two different sources to see how well they could identify people with gastrointestinal disease, gastrointestinal complaints, or a healthy gut. The scoring systems showed similar trends according to gut health status: groups of people with gut bacteria imbalance or gut disease had a different score than groups of people with healthy gut bacteria.

Indexed as

BacteriaDysbiosisGastrointestinal MicrobiomeGastrointestinal TractInflammatory Bowel DiseasesAdultCross-Sectional StudiesFemaleGastrointestinal DiseasesHumansMaleMetagenomicsMiddle AgedPhenotypeYoung Adultgut inflammationgut microbiomeinflammatory bowel diseasekeystone scoremetagenomic aerotolerant predominance index

Identifiers

PMID40558050
PMCPMC12323360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.